Molecular diagnosis of respiratory viruses

Future Microbiology

Volumn 5, Issue 6, 2010, Pages 901-916

  Beck, Eric T ^a   Henrickson, Kelly J ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CHILDREN S HOSPITAL OF WISCONSIN   (United States)

Author keywords

Influenza; Molecular diagnosis; Respiratory virus; Reverse transcription PCR

Indexed keywords

ADENOVIRUS INFECTION; AGAR GEL ELECTROPHORESIS; ANALYTICAL EQUIPMENT; BIOINFORMATICS; DIAGNOSTIC ACCURACY; HUMAN; HUMAN METAPNEUMOVIRUS INFECTION; HYBRIDIZATION; INFLUENZA; LABORATORY AUTOMATION; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; MEDICAL TECHNOLOGY; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; NUCLEIC ACID ANALYSIS; PARAINFLUENZA VIRUS INFECTION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHINOVIRUS INFECTION; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; TISSUE CULTURE; VIRAL RESPIRATORY TRACT INFECTION; VIRUS CHARACTERIZATION; VIRUS DETECTION; VIRUS GENOME; VIRUS ISOLATION; VIRUS MUTATION;

AUTOMATION; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RESPIRATORY TRACT INFECTIONS; SENSITIVITY AND SPECIFICITY; VIRUS DISEASES; VIRUSES;

EID: 77953235450     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.10.48     Document Type: Review

References (87)

1. Mizgerd JP: Lung infection - a public health priority. PLoS Med. 3, 155-158 (2006).
2. Henrickson KJ: Cost-effective use of rapid diagnostic techniques in the treatment and prevention of viral respiratory infections. Pediatr. Ann. 34, 24-31 (2005).
3. Gonzales R, Malone DC, Maselli JH, Sande MA: Excessive antibiotic use for acute respiratory infections in the United States. Clin. Infect. Dis. 33, 757-762 (2001).
4. Templeton KE: Why diagnose respiratory viral infection? J. Clin. Virol. 40, S2-S4 (2007).
5. Woo PC, Chiu SS, Seto WH, Peiris M: Cost-effectiveness of rapid diagnosis of viral respiratory tract infections in pediatric patients. J. Clin. Microbiol. 35, 1579-1581 (1997).
6. Leland DS, Ginocchio CC: Role of cell culture for virus detection in the age of technology. Clin. Microbiol. Rev. 20, 49-78 (2007).
7. Lamb RA, Krug RM: Orthomyxoviridae: The viruses and their replication. In: Field's Virology (Fourth Edition). Knipe DM, Howley PM (Eds). Lippincott, Williams and Wilkins, Philadelphia, PA, USA, 1487-1531 (2001).
8. Wright PF, Webster RG: Orthomyxoviruses. In: Field's Virology (4th Edition). Knipe DM, Howley PM (Eds). Lippincott, Williams and Wilkins, Philadelphia, PA, USA, 1533-1579 (2001).
9. Thompson WW, Shay DK, Weintraub E et al.: Influenza-associated hospitalizations in the United States. JAMA 292, 1333-1340 (2004).
10. Kumar S, Chusid MJ, Willoughby RE et al.: Introduction of a novel swine-origin influenza A (H1N1) virus into Milwaukee, Wisconsin in 2009. Viruses 1, 72-83 (2009).
11. Kumar S, Havens PL, Chusid MJ, Willoughby RE, Simpson P, Henrickson KJ: Clinical and epidemiological characteristics of children with hospitalized 2009 pandemic H1N1 influenza A. J. Ped. Infect. Dis. 29, DOI: 10.1097/INF. 0b013e3181d73e32 (2010) (Epub ahead of print).
12. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ: Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 282, 1440-1446 (1999).
13. Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ: Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J. Infect. Dis. 183, 16-22 (2001).
14. Henrickson KJ, Hoover S, Kehl KS, Weiman H: National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr. Infect. Dis. J. 23, S11-S18 (2004).
15. Glezen WP, Denny FW: Epidemiology of acute lower respiratory disease in children. N. Engl. J. Med. 11, 239-243 (1973).
16. Chidgey SM, Broadley KJ: Respiratory syncytial virus infections: characteristics and treatment. J. Pharm. Pharmacol. S7, 1371-1381 (2005).
17. Collins PL, Chanock RM, Murphy BR: Respiratory syncytial virus. In: Field's Virology (4th Edition). Knipe DM, Howley PM (Eds). Lippincott, Williams and Wilkins, Philadelphia, PA, USA, 1443-1485 (2001).
18. Denny FW, Murphy TF, Clyde WA Jr, Collier AM, Henderson FW: Croup: an 11 year study in a pediatric practice. Pediatrics 71, 871-876 (1983).
19. Reed G, Jewett PH, Thompson J, Tollefson F, Wright PF: Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old. J. Infect. Dis. 175, 807-813 (1997).
20. Counihan ME, Shay DK, Holman RC, Lowther SA, Anderson LJ: Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States. Pediatr. Infect. Dis. J. 20(7), 646-653 (2001).
21. Henrickson KJ: Parainfluenza Viruses. Clin. Microbiol. Rev. 16, 242-264 (2003).
22. Kahn JS: Epidemiology of human metapneumovirus. Clin. Microbiol. Rev. 19, 546-557 (2006).
23. van den Hoogen BG, de Jong JC, Groen J et al.: A newly discovered human pneumovirus isolated from young children with respiratory disease. Nat. Med. 7, 719-724 (2001).
24. Williams JV, Wang CK, Yang CF et al.: The role of human metapneumovirus in upper respiratory tract infections in children: a 20 year experience. J. Infect. Dis. 193, 387-395 (2006).
25. van den Hoogen BG, Osterhaus DM, Fouchier RA: Clinical impact and diagnosis of human metapneumovirus infection. Pediatr. Infect. Dis. J. 23, S25-S32 (2004).
26. Boivin G, de Serres G, Cote S et al.: Human metapneumovirus infections in hospitalized children. Emerging Infect. Dis. 9, 634-640 (2003).
27. Esper F, Boucher D, Weibel C, Martinello RA, Kahn JS: Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children. Pediatrics 111, 1407-1410 (2003).
28. van den Hoogen BG, van Doornum GJJ, Fockens JC et al.: Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J. Infect. Dis. 188, 1571-1577 (2003).
29. McAdam AJ, Hasenbein ME, Feldman HA et al.: Human metapneumovirus in children tested at a tertiary care hospital. J. Infect. Dis. 190, 20-26 (2004).
30. Williams JV, Harris PA, Tollefson SJ et al.: Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N. Engl. J. Med. 350, 443-450 (2004).
31. Shenk TE: Adenoviridae: the viruses and their replication. In: Field's Virology (4th Edition). Knipe DM, Howley PM (Eds). Lippincott, Williams and Wilkins, Philadelphia, PA, USA, 2265-2300 (2001).
32. Gray GC, McCarthy T, Lebeck M et al.: Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006. Clin. Infect. Dis. 45, 1120-1131 (2007).
33. Zhang Y, Bergelson JM: Adenovirus receptors. J. Virol. 79, 12125-12131 (2005).
34. Hierholzer JC: Further subgrouping of the human adenoviruses by differential hemagglutination. J. Infect. Dis. 128, 541-550 (1973).
35. Monto AS: Acute respiratory infections. In: Maxcy-Rosenau-Last Public Health and Preventive Medicine. Last JM, Wallace RB (Eds). Appleton & Lange, Norwalk, CT, USA, 125-131 (1992).
36. Rux JJ, Burnett RM: Adenovirus structure. Hum. Gene Ther. 15, 1167-1176 (2004).
37. Moro MR, Bonville CA, Suryadevara M et al.: Clinical features, adenovirus types, and local production of inflammatory mediators in adenovirus infections. Pediatr. Infect. Dis. J. 28, 376-380 (2009).
38. Price WH: The isolation of a new virus associated with respiratory clinical disease in humans. Proc. Natl Acad. Sci. USA 42, 892-896 (1956).
39. Savolainen C, Blomqvist S, Mulders MN, Hovi T: Genetic clustering of all 102 human rhinovirus prototype strains: serotype 87 is close to human enterovirus 70. J. Gen. Virol. 83, 333-340 (2002).
40. Laine P, Blomqvist, Savolainen C, Andries K, Hovi T: Alignment of capsid protein VP1 sequences of all human rhinovirus prototype strains: conserved motifs and functional domains. J. Gen. Virol. 87, 129-138 (2006).
41. Kistler AL, Webster DR, Rouskin S et al.: Genome-wide diversity and selective pressure in the human rhinovirus. Virol. J. 4, 40 (2007).
42. Tapparel C, Junier T, Gerlach D et al.: New complete genome sequences of human rhinoviruses shed light on their phylogeny and genomic features. BMC Genomics 8, 224 (2007).
43. Palmenberg AC, Spiro D, Kuzmickas R et al.: Sequencing and analyses of all known human rhinovirus genomes reveals structure and evolution. Science 324, 55-59 (2009).
44. Makela MJ, Puhakka T, Ruuskanen O et al.: Viruses and bacteria in the etiology of the common cold. J. Clin. Microbiol. 36, 539-542 (1998).
45. Winther B, Hayden FG, Hendley JO: Picornavirus infections in children diagnosed by RT-PCR during longitudinal surveillance with weekly sampling: association with symptomatic illness and effect of season. J. Med. Virol. 78, 644-650 (2006).
46. Peltola V, Waris M, Osterback R, Susi P, Hyypi T, Ruuskanen O: Clinical effects of rhinovirus infections. J. Clin. Virol. 43, 411-414 (2008).
47. Winther B, Gwaltney JM Jr, Mygind N, Turner RB, Hendley JO: Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA 256, 1763-1767 (1986).
48. Henrickson KJ: Advances in the laboratory diagnosis of viral respiratory disease. Pediatr. Infect. Dis. J. 23, S6-S10 (2004).
49. Gubareva LV, Webster RG, Hayden FG: Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. Antivir. Res. 53, 47-61 (2002).
50. Wetherall NT, Trivedi T, Zeller J et al.: Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J. Clin. Microbiol. 41, 742-750 (2003).
51. Deyde VM, Sheu TG, Trujillo A et al.: Detection of molecular markers of drug resistance in 2009 pandemic influenza (H1N1) viruses by pyrosequencing. AntimicroB. Agents. Chemother. 54, 1102-1110 (2010).
52. Brandt CD, Kim HW, Vargosko AJ et al.: Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome. Am. J. Epidemiol. 90, 484-500 (1969).
53. Brandt CD, Kim HW, Jeffries BC et al.: Infections in 18,000 infants and children in a controlled study of respiratory tract disease. II. Variation in adenovirus infections by year and season. Am. J. Epidemiol. 95, 218-227 (1972).
54. Jartti, Lehtinen P, Vuorinen T, Koskenvuo M, Ruuskanen O: Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J. Med. Virol. 72, 695-699 (2004).
55. Winther B, Hayden FG, Hendley JO: Picornavirus infections in children diagnosed by RT-PCR during longitudinal surveillance with weekly sampling: association with symptomatic illness and effect of season. J. Med. Virol. 78, 644-650 (2006).
56. Wright PF, Deatly AM, Karron RA et al.: Comparison of results of detection of rhinovirus by PCR and viral culture in human nasal wash specimens from subjects with and without clinical symptoms of respiratory illness. J. Clin. Microbiol. 45, 2126-2129 (2007).
57. Deiman B, van Aarle P, Sillekens P: Characteristics and applications of nucleic acid sequence-based amplification (NASBA). Mol. Biotechnol. 20, 163-179 (2002). (Pubitemid 34165499)
58. Savan R, Kono T, Itami T, Sakai M: Loop-mediated isothermal amplification: an emerging technology for detection of fish and shellfish pathogens. J. Fish Dis. 28, 573-581 (2005).
59. Mori Y, Notomi T: Loop-mediated isothermal amplification (LAMP): a rapid, accurate, and cost-effective diagnostic method for infectious diseases. J. Infect. Chemother. 15, 62-69 (2009).
60. Bustin SA: Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25, 169-193 (2000).
61. Bustin SA; Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J. Mol. Endocrinol. 29, 23-39 (2002).
62. Bustin SA, Benes V, Nolan T, Pfaffl MW: Quantitative real-time RT-PCR - a perspective. J. Mol. Endocrinol. 34, 597-601 (2005).
63. Bustin SA, Mueller R: Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. Clin. Sci. 109, 365-379 (2005).
64. Lukhtanov EA, Lokhov SG, Gorn VV, Podyminogin MA, Mahoney: Novel DNA probes with low background and high hybridization-triggered fluorescence. Nucleic Acids Res. 35, e30 (2007).
65. Ginzinger DG: Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp. Hematol. 30, 503-512 (2002).
66. Lam WY, Yeung ACM, Tang JW et al.: Rapid multiplex nested PCR for detection of respiratory viruses. J. Clin. Microbiol. 45, 3631-3640 (2007).
67. Kim SR, Ki C-S, Lee NY: Rapid detection and identification of 12 respiratory viruses using a dual priming system-based multiplex PCR assay. J. Virol. Methods 156, 111-116 (2009).
68. Brittain-Long R, Nord S, Olofsson S, Westin J, Anderson LM, Lindh M: Multiplex real-time PCR for detection of respiratory tract infections. J. Clin. Virol. 41, 53-56 (2008).
69. Bose ME, Beck ET, Ledeboer N et al.: Rapid semi-automated subtyping of influenza species during the 2009 swine origin influenza A virus epidemic in Milwaukee, WI. J. Clin. Microbiol. 47, 2779-2786.
70. Beck ET, Jurgens LA, Kehl SC et al.: Development of a rapid automated influenza A, influenza B, and respiratory syncytial virus A/B multiplex real-time RT-PCR assay and its use during the 2009 H1N1 swine-origin influenza virus epidemic in Milwaukee, Wisconsin. J. Mol. Diagn. 12(1), 74-81 (2010).
71. Fan J, Henrickson KJ: Rapid diagnosis of human parainfluenza virus type 1 infection by quantitative reverse transcription-PCR-enzyme hybridization assay. J. Clin. Microbiol. 34, 1914-1917 (1996).
72. Fan J, Henrickson KJ, Savatski LL: Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse-transcription-polymerase chain reaction-enzyme hybridization assay (Hexaplex). Clin. Infect. Dis. 26, 1397-1402 (1998).
73. Kumar S, Wang L, Fan J et al.: Detection of 11 common viral and bacterial pathogens causing community-acquired pneumonia or sepsis in asymptomatic patients by using a multiplex reverse transcription-PCR assay with manual (enzyme hybridization) or automated (electronic microarray) detection. J. Clin. Microbiol. 46, 3063-3072 (2008).
74. He J, Bose ME, Beck ET et al.: Rapid multiplex reverse transcription-PCR typing of influenza A and B virus, and subtyping of influenza A virus into H1, 2, 3, 5, 7, 9, N1 (human), N1 (animal), N2, and N7, including typing of novel swine origin influenza A (H1N1) virus, during the 2009 Outbreak in Milwaukee, Wisconsin. J. Clin. Microbiol. 47, 2772-2778 (2009).
75. He J, Kraft AJ, Fan J et al.: Simultaneous detection of CDC category "A" DNA and RNA bioterrorism agents by use of multiplex PCR & RT-PCR enzyme hybridization assays. Viruses 1, 441-459 (2009).
76. Henrickson KJ, Kraft A, Shaw J, Carter D: Comparison of electronic microarrary (NGEN RVA) to enzyme hybridization assay (Hexaplex) for multiplex RT-PCR detection of common respiratory viruses in children. Clin. Microbiol. Newsl. 29, 113-119 (2007).
77. Pasloske BL, Walkerpeach CR, Obermoeller RD, Winkler M, DuBois DB: Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards. J. Clin. Microbiol. 36, 3590-3594 (1998).
78. Rosenstraus M, Wang Z, Chang S-Y, DeBonville D, Spadoro JP: An internal control for routine diagnostic PCR: design, properties, and effect on clinical performance. J. Clin. Microbiol. 36, 191-197 (1998).
79. Hoorfar J, Cook N, Malorny B et al.: Making internal amplification control mandatory for diagnostic PCR. J. Clin. Microbiol. 41, 5835 (2003).
80. Merante F, Yaghoubian S, Janeczko R: Principles of the xTAG™ respiratory viral panel assay (RVP assay). J. Clin. Virol. 40(Suppl. 1), S31-S35 (2007).
81. Pabbaraju K, Tokaryk KL, Wong S, Fox JD: Comparison of the Luminex xTAG respiratory viral panel with in-house nucleic acid amplification tests for diagnosis of respiratory virus infections. J. Clin. Microbiol. 46, 3056-3062 (2008).
82. Henrickson KJ, Hall CB: Diagnostic assays for respiratory syncytial virus disease. Pediatri. Infect. Dis. J. 26, S36-S40 (2007).
83. Gall A, Hoffman B, Harder T, Grund C, Hoper D, Beer M: Design and validation of a microarray for detection, hemagglutinin subtyping, and pathotyping of avian influenza viruses. J. Clin. Microbiol. 47, 327-334 (2009).
84. Huang Y, Tang H, Duffy S et al.: Multiplex assay for simultaneously typing and subtyping influenza viruses by use of an electronic microarray. J. Clin. Microbiol. 47, 390-396 (2009).
85. Lin B, Malanoski AP, Wang Z et al.: Universal detection and identification of avian influenza virus by use of resequencing microarrays. J. Clin. Microbiol. 47, 988-993 (2009).
86. Bose ME, Littrell JC, Patzer AD et al.: The influenza primer design resource: a new tool for translating influenza sequence data into effective diagnostics. Influenza Other Respi. Viruses 2, 23-31 (2008).
87. Voelkerding KV, Dames SA, Durtschi JD: Next-generation sequencing: from basic research to diagnostics. Clin. Chem. 55, 641-658 (2009).